Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat

David L Mattson1, Leilani James, Elizabeth A Berdan

  • 1Department of Physiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. dmattson@mcw.edu

Insights

Immune cell activation in the kidney contributes to high salt-induced hypertension and renal disease in Dahl rats. Suppressing immune cells with mycophenolate mofetil (MMF) reduced blood pressure and kidney damage.

Area of Science:

  • Nephrology
  • Immunology
  • Cardiovascular Medicine

Background:

  • Hypertension and renal disease are significant health concerns.
  • The role of immune cell activation and infiltration in the kidney during hypertension development is not fully understood.
  • Dahl salt-sensitive (SS/Mcw) rats are a common model for studying salt-induced hypertension.

Purpose of the Study:

  • To investigate the role of immune cell activation and infiltration in the kidneys of Dahl SS/Mcw rats during the development of hypertension and renal disease.
  • To determine the effect of immunosuppression on blood pressure and renal function in this model.

Main Methods:

  • Dahl SS/Mcw rats were fed a high-salt (4.0% NaCl) diet.
  • Rats were treated with mycophenolate mofetil (MMF), an immunosuppressive agent, or a vehicle control.
  • Blood pressure, protein excretion, albumin excretion, and creatinine clearance were measured.

Main Results:

  • MMF treatment significantly decreased T and B cell markers in the kidneys.
  • Mean arterial blood pressure was significantly lower in MMF-treated rats compared to controls.
  • Protein and albumin excretion rates were significantly reduced in MMF-treated rats.

Conclusions:

  • Immune system activation and renal immune cell infiltration play a crucial role in the development of hypertension and renal disease in Dahl SS/Mcw rats on a high-salt diet.
  • Immunosuppression with MMF ameliorates hypertension and reduces renal damage in this model.
  • Targeting immune pathways may be a potential therapeutic strategy for salt-induced hypertension and kidney disease.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...